Table 1 Characteristics of the study cohort
Variable | N | Mean | SD |
|---|---|---|---|
Age (years) | 562 | 60.10 | 12.42 |
Angiopoeitin-2 (pg/mL) | 532 | 4742.68 | 3897.90 |
Left ventricular ejection fraction (%) | 559 | 56.64 | 13.07 |
Body mass index (kg/m2) | 562 | 30.80 | 7.64 |
HDL cholesterol (mg/dL) | 429 | 49.06 | 14.74 |
LDL cholesterol (mg/dL) | 397 | 106.55 | 41.67 |
Total cholesterol (mg/dL) | 430 | 185.13 | 48.40 |
Triglycerides (mg/dL) | 421 | 160.28 | 133.70 |
Systolic blood pressure (mmHg) | 562 | 145.77 | 24.34 |
Diastolic blood pressure (mmHg) | 562 | 82.15 | 13.77 |
DNAmAge (years) | 562 | 64.90 | 10.89 |
PhenoAge (years) | 562 | 51.26 | 12.39 |
GrimAge (years) | 562 | 57.91 | 10.32 |
Horvath age acceleration (years) | 562 | 4.79 | 6.60 |
Phenotypic age acceleration (years) | 562 |  − 8.85 | 7.73 |
Grim age acceleration (years) | 562 |  − 2.20 | 6.45 |
Variable | Total | N | Percent (%) |
|---|---|---|---|
Sex (Women) | 562 | 234 | 41.64 |
Race (Caucasian) | 562 | 348 | 61.92 |
History of Smoking | 562 | 248 | 44.13 |
All-cause mortality | 562 | 223 | 39.68 |
Peripheral artery disease | 562 | 33 | 5.87 |
Congestive heart failure | 546 | 145 | 26.56 |
Coronary artery disease | 557 | 299 | 53.68 |
History of hypertension | 562 | 384 | 68.33 |
History of diabetes | 562 | 170 | 30.25 |
History of dyslipidemia | 562 | 323 | 57.47 |